Advaxis and UC San Francisco to Evaluate Cancer Immunotherapy Constructs in Prostate Cancer|
Advaxis, Inc. announced that it has signed an agreement with the University of California, San Francisco, under which Lawrence Fong, M.D. will evaluate several new immunotherapy constructs, in addition to ADXS-PSA, each built on the Advaxis proprietary technology. [Advaxis, Inc.]
Tesaro and Anaptysbio Announce Collaboration and Exclusive Worldwide License Agreement for Multiple Immuno-Oncology Programs
TESARO, Inc. and AnaptysBio, Inc. announced an exclusive, worldwide license agreement and immuno-oncology antibody collaboration. Therapeutic antibodies selected from these programs will form the basis of a strategic platform that will enable TESARO to develop novel monotherapy and combination-based approaches with immuno-oncology and other anti-cancer agents in a variety of indications. [TESARO, Inc.]
MD Anderson, MedImmune Join Forces to Advance Cancer Immunotherapy
The University of Texas MD Anderson Cancer Center and MedImmune will collaborate through MD Anderson’s Moon Shots Program to develop therapies that unleash patients’ immune systems to attack their cancers. [The University of Texas MD Anderson Cancer Center]
From our sponsor:
View immunology lectures, protocols and other resources on the Human Immunology Portal.
Have we missed an important article or publication in Human Immunology News?
Click here to submit!
Comments or Suggestions? Submit your feedback here.